interface, since other F-actin-rich structures, such as stress fibers, do not contain cortactin.
Cortactin in the Test Tube
The cortactin family is composed of two gene products: the ubiquitously expressed cortactin with its alternatively spliced variants and the hematopoietic lineage cell-specific protein (HS1), present exclusively in blood cells (84, 96) . Human cortactin is encoded by the CTTN (formerly EMS1) gene within the chromosome region 11q13, a locus often amplified in various 352 1548-9213/05 8.00 ©2006 Int. Union Physiol. Sci./Am. Physiol. Soc.
Cortactin was discovered 15 years ago in Thomas
Parson's laboratory as a filamentous actin-binding protein and a major substrate of the oncogenic tyrosine kinase v-Src (104, 105) . These two signature features (F-actin binding and phosphorylation by various kinases) have initiated the continuously growing career of this protein and focused attention on cortactin as a candidate molecule that might link structural (cytoskeletal) organization with signal transduction. The recognition that cortactin binds to and potentiates the activity of the actin-related protein 2/3 (Arp2/3) complex (94, 98, 102) , a recently discovered central actin-nucleating factor (36) , gave strong experimental support for this notion. Moreover, in addition to being a likely bridge between receptor-mediated or mechanical signals on one hand and actin skeleton restructuring on the other, cortactin has emerged as a key protein involved in the coordination of membrane dynamics and cytoskeleton remodeling (81) . Indeed cortactin is always "there" when changes in the cortical actin skeleton initiate, modify, or accompany major membrane events. Thus cortactin accumulates in lamellipodia where the freshly polymerized F-actin meshwork pushes the membrane envelope of migrating cells (8, 61, 101) at the leading edge of path-finding axons (15, 52, 53) ; in the invadopodia by which metastatic tumor cells penetrate the basement membrane (5, 6) ; in podosomes, where bone-resorbing osteoclasts seal off the surface to be digested (21, 60) ; at intercellular contacts, where cells strengthen or disassemble their bonds (27, 28, 34) ; around endocytic vesicles, which move toward the cytosol in an actindependent manner (12, 45) ; at the entry sites of intracellular pathogens, which propel themselves by harnessing the F-actin polymerization machinery (for review, see Ref. 85) ; or at the periphery of mechanically challenged cells, which reinforce their cytoskeleton (3, 22) . Clearly, the common denominator of these diverse events is not simply the presence of F-actin but the formation of a dynamic membrane-cytoskeleton tumors, including carcinomas of the head and neck, ovary, breast, liver, and lung (16, 74, 77, 83) . Amplification of the cortactin gene or increased expression of the cortactin mRNA [e.g., in bladder cancer (7) ] is associated with metastasis and poor prognosis, implicating cortactin as a factor in invasiveness. The cortactin protein is composed of ~550 amino acids (FIGURE 1A) . The N-terminal half of the molecule includes the N-terminal acidic region (NTA), which harbors the DDW motif, the binding site for the Arp3 component of the Arp2/3 complex, followed by 6.5 tandem repeats of 37 amino acids responsible for F-actin binding (103) . Thus this half of the molecule is responsible for coupling cortactin to structural elements of the cytoskeleton. The COOH-terminal half is composed of an ␣-helical domain of unknown function, followed by a proline-serine-threonine-rich region (PST), which also harbors critical tyrosine residues, and finally a Src homology 3 (SH3) domain. Thus the COOH-terminal half of cortactin can be regarded as the regulatory segment of the protein: the PST is a target of various serine/threonine kinases, of which p21-activated kinase (PAK) (97) and the MAP kinase ERK (11, 64) have been identified and implicated in the phosphorylation of S405 and S418, whereas three critical tyrosine residues (Y421/466/482) are targeted (directly or indirectly) by members of the Src kinase family v-Src, c-Src, and Fyn (39, 46, 47, 104) ; other non-receptor tyrosine kinases such as FER (46, 50) and Syk (30) ; and the hepatocytes growth factor receptor kinase MET (18) . The SH3 domain is a hub of interactions through which cortactin has been shown to associate with the proline-rich regions of a plethora of proteins, thereby linking cortactin-mediated actin remodeling to the various specific loci and processes. The SH3-binding partners include the Arp2/3-stimulating Wiscott-Aldrich protein N-WASP (70) and the WASP-interacting protein WIP (51) , missing in metastasis protein MIM (59), the endocytic GTPase dynamin-2 (67), the receptor endocytosis-regulator scaffold CD2AP (63) , the tight junction (TJ) protein ZO-1, the synaptic adaptor protein Shank2 (23), the Cdc42 activator guanine nucleotide exchange factor (GEF) faciogenital dysplasia 1 (FGD1) (37), CBP90, a brain-and mammary gland-specific protein of unknown function (44, 72) , and the contractilityenhancing myosin light chain kinase (24) . This list clearly indicates that a remarkably diverse array of processes employs cortactin as their link to cytoskeleton remodeling.
The breakthrough in our understanding of the basic function of cortactin was the discovery that it associates with and acts as an activator of the Arp2/3 complex (94, 99, 102) . This seven-protein complex is the main mediator of de novo F-actin nucleation and Factin branch assembly (36) . When activated, the Arp2/3 complex binds to the side of an actin filament (the mother filament) and attaches, as a pointed-end capper, a monomeric (G)-actin subunit, the barbed end of which initiates the formation of a daughter filament in a 70-degree angle. This so-called dendritic nucleation leads to the formation of a branched actin meshwork (4) (FIGURE 1B). Arp2/3 is activated by nucleation promoting factors (NPFs), the most important of which are the members of the WASP superfamily and cortactin. In vitro, cortactin is a substantially 353 PHYSIOLOGY • Volume 21 • October 2006 • www.physiologyonline.org REVIEWS FIGURE 1. The structure and interactions of cortactin A: the various functional domains are shown on top, whereas the different proteins cortactin binds to and the kinases that phosphorylate it are indicated at bottom. B: dendritic nucleation. The activated Arp2/3 complex binds to the side of a mother filament (M) to nucleate a daughter filament (D). The schemes show two potential (nonexclusive) configurations of cortactin arrangement near the branch point. In both cases, the N terminus of cortactin binds to the Arp2/3 complex, whereas the F-actin binding repeats interact either with the daughter filament or with the mother filament as suggested in Refs. 93 and 98, respectively. During the finalization of this review, Pant et al. (76) published a study in which they used electron microscopy and three-dimensional reconstruction to investigate the geometry of the interaction between purified actin and the cortactin N terminus. They found that binding of cortactin to actin subdomain-1 widens the gap between the intertwining actin filaments. They propose a model in which cortactin binding to the mother filament might facilitate the recruitment of WASP at this locus. The COOH terminal SH3 domain can associate with a variety of partners (X).
next sections) as well. Moreover, although the concept that phosphorylation modifies the availability of SH3 is an attractive one, this does not have to be always negative for tyrosine and positive for serine phosphorylation. Rather, phosphorylation may selectively alter the relative affinity for individual partners. Consistent with such a notion, tyrosine phosphorylation seems to promote the SH3-dependent binding of cortactin to the adaptor protein CD2AP (63) , to myosin light-chain kinase (MLCK) (24) , and according to our preliminary data to dynamin. Furthermore, serine phosphorylation in itself may be neither sufficient nor necessary to induce cortactin translocation to the cortical skeleton (42) . Conceivably, an initial assembly of the F-actinArp2/3 complex might be enough to recruit cortactin. In addition to regulating SH3 affinity, tyrosine phosphorylation may promote SH2 domain-dependent interactions [e.g., with Fer and Src (50, 73) ] and was suggested to decrease the actin cross-linking or bundling activity of cortactin (39) . However, the actin cross-linking capability of cortactin is disputed, and the molecular basis of such an effect is not clear (103) . Finally, tyrosine phosphorylation may also regulate the cellular level of cortactin, since the phosphorylated form is preferentially degraded by the protease calpain (40) .
What may be necessary for proper cortactin function is not as much a net change in serine or tyrosine phosphorylation but a continuous cycle of phosphorylation and dephosphorylation allowing the dynamic recycling of the protein. Thus we proposed that tyrosine phosphorylation might be required to mobilize cortactin that had been incorporated into the F-actin meshwork (29) . This way cortactin may be liberated from the base of the lamellipodium, and after dephosphorylation it may be re-incorporated at the rapidly protruding leading edge. Consistent with this model, actin organization per se impacts on cortactin phosphorylation: actin depolymerization promotes Fermediated cortactin phosphorylation, whereas cortactin associated with F-actin seems to be less accessible for tyrosine phosphorylation (29) . Future studies should test the phosphorylation-dependent recycling model.
Cortactin at the Lamellipodia and the Leading Edge
A variety of growth factors, e.g., PDGF, EGF (48, 101), sphingosine-1-phosphate (56), shear stress (25) , and hyperosmotic shock (22) , send cortactin, presumably via the activation of the small GTPase Rac (101) , to the cell periphery and induce its accumulation in lamellipodia and membrane ruffles (FIGURE 2A). Tyrosine phosphorylation of cortactin is not required for this process (22, 33) ; rather, it might be a consequence of translocation (33) weaker activator of F-actin assembly than N-WASP (99, 102); however, it has a unique property: it simultaneously binds to F-actin (as opposed to G-actin like the WASP members) and thereby couples the Arp2/3-dependent actin polymerization to an existing actin filament. In fact, cortactin has a 20-fold higher affinity for F-actin than the Arp2/3 complex (94). Conversely, cortactin has a much higher affinity for Arp2/3 once the latter has been associated with an actin filament (93) . Moreover, cortactin has a 15-fold higher affinity for ATP/ADP-Pi-actin than for ADP-actin, which means that it preferentially binds to "young," i.e., freshly incorporated, actin molecules (8) . Thus cortactin associates with the "hot spots" where the action takes place, i.e., at branch points with rapidly polymerizing daughter filaments. In addition to promoting nucleation and branching, it also stabilizes the newly formed branches (99) . There are a number of potential mechanisms whereby cortactin can stimulate Arp2/3. First, it directly binds to Arp3, inducing a conformational change. Since its binding site is only partially overlapping with WASP (98), WASP-cortactin-Arp2/3 may form a ternary complex. Alternatively, cortactin can replace WASP on Arp2/3 (93), thereby stabilizing the branch and liberating WASP for a new cycle. A second mechanism is that cortactin binds WASP via its SH3 domain. The cortactin SH3 domain may also contribute by binding the WASP-activating WIP (51) and dynamin (82) , which has also been shown to enhance actin nucleation. Further fine tuning in regulation is provided by the G-actin-and cortactin-interacting protein MIM, which promotes cortactin-dependent but suppresses N-WASP-mediated actin polymerization. Thus MIM may modify cell motility by selecting among various Arp2/3 activators (59). Finally, cortactin may recruit FGD1, which via its GEF activity stimulates Cdc42, a direct activator of WASP (49) .
The question arises how cortactin phosphorylation affects its actin-nucleating activity. This is a simple question with no clear answer. There is no evidence that tyrosine (or serine) phosphorylation would directly affect the Arp2/3-stimulating effect of cortactin. However, phosphorylation can modify the interaction of cortactin with other proteins, which may have a major impact. Recently, an "on-off switch" or "SY switch" paradigm has been put forward, according to which ERK-mediated serine phosphorylation (S) promotes, whereas Src-mediated tyrosine phosphorylation (Y) inhibits, the SH3-dependent interaction of cortactin with WASP and the consequent actin polymerization (64) . This view assigns a negative (off ) role for tyrosine phosphorylation, which is consistent with previous findings that osmotic stress-induced tyrosine phosphorylation promotes the disassembly of cortactin and Arp3 (22) . However, the picture is bound to be more complex since cortactin tyrosine phosphorylation is associated with and appears to be necessary for many positive functions (e.g., invasiveness; see sion enhances cell migration (38, 78) , tyrosine phosphorylation-incompetent or SH3-deleted mutants reduce the motility of fibroblasts and epithelial cells (38, 54) , and siRNA-mediated cortactin downregulation inhibits cell migration and matrigel invasion of breast epithelial (95) or mammary carcinoma cells. These observations and the biochemical properties of cortactin would suggest that this protein is indispensable for lamellipodium formation and analogous phenomena such as cell spreading. However, rather surprisingly, the overall picture is not as clear and is not devoid of contradictions. For example, Bryce et al. (8) found that cortactin was necessary for lamellipodial persistence, i.e., in the absence of cortactin, peripheral protrusions were instable and rapidly retracted, consistent with a branch-stabilizing role. In contrast, Kempiak et al. (48) reported that, on cortactin downregulation, mammary tumor cells exhibited enhanced lamellipod-like extension toward EGF-covered beads, although their overall motility was less. Furthermore, using the same cell type, it was found that cortactin downregulation resulted in near-normal EGF-induced lamellipod extension but delayed lamellipod retraction (S. Weed, personal communication), whereas our studies in the same system showed a grossly impaired lamellipod extension that was restored by cortactin retransfection, an effect requiring both the critical tyrosines and the SH3 domain (17) . Moreover, Illes et al. (43) reported that siRNA-mediated reduction in cortactin caused 70% inhibition of cell spreading, whereas van Rossum et al. (95) found that the absence of cortactin accelerated spreading and increased the overall spread area by 25-50%. In this study, lamellipod extension was not affected by cortactin downregulation, letting the authors conclude that cortactin is either not required for this process or the remaining cortactin after siRNA treatment might be sufficient. Thus, whereas everybody agrees that cortactin and its tyrosine phosphorylation are important for efficient cell migration, the role of cortactin in the subtleties of lamellipodial dynamics remains unresolved. In addition to modifying F-actin dynamics at the tip of the leading edge, another way how cortactin might affect lamellipodial dynamics is via an impact on the assembly of focal adhesions at the base of the lamellipodium. Normal focal contacts appear to be required for the generation of a continuous, broad lamellipodium at the leading edge (91) , and cortactin downregulation decreased the rate of peripheral adhesion assembly as visualized by GFP-paxillin (8) .
Nonetheless, as the above description shows, the topic is loaded with controversies. The reported discrepancies might be partially due to the extent of cortactin downregulation: conceivably, cortactin might be involved both in lamellipodial extension and retraction, but through distinct mechanisms that may exhibit different requirements in terms of cortactin concentration. Indeed, a recent study suggests that focal changes in cortactin concentration via cortactin degradation (proteolysis) might be an important regulatory factor in cell motility, since the expression of calpain-resistant cortactin impaired cell migration and increased transient membrane protrusions (79) . Clearly, further research is warranted to define the role of cortactin at the leading edge.
Cortactin at Invadopodia and Podosomes
There is consensus with regard to the requirement of cortactin for invasiveness and for the formation and function of invadopodia. These structures are ventral membrane protrusions or finger-like processes that penetrate into the surrounding extracellular matrix (ECM) and contain proteolytic enzymes such as matrix metalloproteases (66) (FIGURE 2B). Cortactin is highly enriched in invadopodia where it forms a complex with paxillin and protein kinase C (PKC). Importantly, microinjection of anti-cortactin antibodies suppressed matrix degradation at invadopodia (5) and cortactin downregulation inhibited the formation of these structures (1). Cortactin is highly tyrosine phosphorylated in active invadopodia, and the level of its tyrosine phosphorylation shows a linear correlation with the concomitant matrix degradation (6) . Thus tyrosine phosphorylation of cortactin appears to be a positive regulator of invasion. It remains an intriguing question how cortactin and its phosphorylation regulate invadopodia and the activity of matrix metalloproteases.
Podosomes are actin-rich structures that represent another type of matrix-cell surface interface. These structures, originally described in v-Src-transformed cells (9, 60) , are composed of a core with columnar arrangement of F-actin and actin-binding proteins that protrude into the cytosol from the ventral surface. This region is surrounded by a ring containing paxillin, vinculin, and talin, through which the core is anchored to integrins (FIGURE 2C). In certain cases, these actin structures are arranged around long, intruding membrane tubules. Podosomes are also key sites of ECM remodeling: they are believed to seal off and modify portions of the ECM under the cell. Macrophages and osteoclasts are the richest in podosomes, but many other cell types also contain these structures. Podosome formation can be induced by active Src, PKC, or PAK (10, 107) , and cortactin appears to be a key component in the process, since its knockdown inhibits podosome assembly (107) . Podosome genesis occurs in two phases: initially "prepodosomal," cortactin-containing clusters occur near the end of stress fibers. Recruitment of cortactin to these precursor sites required an intact N-WASP-binding SH3 domain. Cortactin then may facilitate the assembly of columnar F-actin structures. In this second phase, more cortactin was recruited to the REVIEWS FIGURE 2. The playgrounds of cortactin Cortactin, as a key organizer and coordinator of cytoskeleton remodeling and membrane dynamics, accumulates in various functional hot spots. It is highly enriched in lamellipodia (A), in which the branching F-actin meshwork pushes the membrane envelope of migrating cells. It is also necessary for the formation and function of invadopodia (B) and podosomes (C), two important matrix-membrane interfaces. The presence of cortactin is required for the efficient recruitment of the matrix-degrading metalloproteases (MMP) to invadopodia (B). In these structures, cortactin forms a complex with paxillin and protein kinase C (PKC). In podosomes (or foot processes), cortactin is a constituent of the central actin column (core), which is connected to the matrix by a peripheral ring structure, composed of integrins, and adaptors proteins (vinculin, paxillin). Cortactin is a dynamic regulator of the excitatory synapse as well (D), where it links the adaptor protein Shank to the cytoskeleton. Shank is coupled to ionotropic (I) glutamate receptors through the postsynaptic density protein-95 (PSD) and the guanylate kinase-associated protein (GKAP), and to metabotropic (M) glutamate receptors through Homer. Cortactin (via its tyrosine phosphorylation) regulates the stability of the postsynaptic density. Cortactin is a key component of the endocytic machinery too (E), where it may participate in the invagination of the forming endosomes and the coordination of this process with vesicle scission through interaction with dynamin. Subsequently, cortactin may contribute to the actin comet tail-driven intracellular movement of the formed vesicle. Cortactin has been implicated as a regulator of various intercellular junctions (F). It associates with tight junctions (TJ) through Zonula occludens 1 (ZO-1). Its role is better understood in adherens junctions (AJ), composed of intercellular adhesion molecules cadherins (cad) connected to the actin skeleton via ␤-catenin (␤) and ␣ catenin (␣). Currently, it is not clear whether cortactin associates with cadherins directly or through yet unidentified protein(s) (designated with "?" in the figure). Cortactin is important for cytoskeletal organization at the AJs, a requisite for junction formation and strengthening. Local tyrosine phosphorylation of cortactin by Fer is required for this process.
growing podosome, but this time in a SH3-independent but F-actin binding region-dependent manner (100). Cortactin becomes highly tyrosine phosphorylated in podosomes, but this process is not necessary for cortactin recruitment (107) . Finally, cortactin has been implicated in local inhibition of contractility at the podosome by promoting the dispersion of myosin and tropomyosin at these sites (10) . The mechanism and significance of this phenomenon, as well as the way whereby cortactin contributes to the podosome functions (e.g., focal bone resorption) are promising areas for future investigations. Indeed, while this paper was under review, Tehrani et al. (89) published an elegant study showing that siRNA-induced cortactin depletion in osteoclasts abolished podosome formation and bone resorption. These functions were shown to require cortactin tyrosine phosphorylation but not an intact SH3 domain.
Cortactin at the Growth Cone and the Synapse
Intriguing new research identifies cortactin as a central player in a number of neuron-specific functions including growth cone formation (15, 23) , axon guidance (path finding) (52, 53) , neuronal polarization (57), dendritic spine morphogenesis (synaptogenesis) (35) , differential neurotransmitter (GABA) receptor expression (15) , and the modulation of voltage-gated K + channels (32) .
Cortactin is enriched in growth cones of developing neurons (23) , and its suppression resulted in shorter processes and growth cones with enlarged filopodia (15) . Its tyrosine phosphorylation at this locus has been suggested to act as a signal for repulsive growth cone turning during EphA-receptor mediated retinal axon guidance (53) . Again, the picture is complex. For example, heparin-binding growth-associated molecule (HB-GAM), an important neurite outgrowth-promoting protein and spatial cue involved in neuronal path finding, induced cortactin tyrosine phosphorylation on binding to its receptor, N-syndecan. This event was associated with complex formation among N-syndecan, cortactin, and Src, and was concomitant with enhanced neurite growth (52) . Thus, depending on the context, cortactin and its tyrosine phosphorylation may act as path-maintaining or repulsive signals.
It has been raised that cortactin might also be involved in neuronal polarization, the intriguing process whereby a single neurite is selected to become the axon. A recent study indicates that Fer kinase is concentrated in growth cones, and inhibition of this enzyme delays the dendrite-axon conversion (57) . The two most important substrates of Fer in the growth cone are cortactin and p120 catenin [or its relative ␦-catenin, which was shown to associate with cortactin (65) ]. According to the current hypothesis, Fermediated phosphorylation might inhibit extensive actin filament branching, and this may be necessary for the rapid elongation of the forming axon. Cortactin may also play a role in regulating neurite branching: complex formation between ␦-catenin and cortactin has been proposed to promote the extension of unbranched primary processes, whereas tyrosine phosphorylation disrupted this complex and resulted in enhanced branching in PC12 cells (65) . It remains a challenge to integrate and reconcile these findings with the mechanism of axon selection.
A major step in our understanding of the role of cortactin at the synapse was the discovery that cortactin interacts with members of the Shank family, scaffold proteins of the postsynaptic density (23, 71) . Shank is located under the membrane linked to both ionotropic and metabotropic glutamate receptors through various adaptor proteins (PSD-95, GKAP and Homer, respectively) (26) . The proline-rich region of Shank binds to the SH3 domain of cortactin, thereby forming a multiprotein bridge between excitatory receptors and the cytoskeleton (FIGURE 2D ). In addition, cortactin plays a key role in the morphogenesis of dendritic spines as verified by the findings that its downregulation resulted in spine depletion, whereas its overexpression caused spine elongation (35) . The interaction between cortactin and dynamin-3 appears to be critical for dendritic spine maturation: the presence of this complex facilitates the formation of immature dendritic filopodia, whereas its disruption (or dissociation) leads to formation of mature dendritic spines with postsynaptic densities (31) . Furthermore, synaptic transmission is a dynamic regulator of cortactin distribution and therefore postsynaptic cytoskeleton organization. For example, NMDA receptor stimulation induced cortactin redistribution from the spine to the shaft (35) , an effect due to Src family-mediated tyrosine phosphorylation of cortactin (41), whereas brain-derived neurotrophic factor triggered ERKmediated serine phosphorylation of cortactin, concomitant with its translocation from the shaft to the spines (41) . These fascinating findings suggest that cortactin is involved in the function-dependent remodeling of the synapse: overstimulation of NMDA receptors removes cortactin and thereby collapses dendritic spines, which may serve as a negative feedback mechanism. In contrast, neurotrophic factors use cortactin to solidify synaptic transmission. In addition, cortactin was reported to interact with the Kv1. invasive phenotype of cortactin-overexpressing tumor cells (92) . Finally, it is worth mentioning that the dynamin-cortactin interaction is not limited to the endocytic machinery; in fact, these proteins colocalize also in the Golgi-apparatus (13), invadopodia, podosomes, and lamellipodia (75) . As mentioned, dynamin facilitates the actin-nucleating effect of cortactin (82) , and it has a substantial impact on lamellipodial kinetics and cell shape determination (55, 67) . Furthermore, our ongoing studies suggest that in lamellipodia cortactin might recruit dynamin (and not the other way around as at the CCP) and that their interaction may be facilitated by tyrosine phosphorylation. Clearly, the dynamin-cortactin complex is a key component of the interplay between membrane dynamics and cytoskeleton remodeling.
Cortactin at Intercellular Junctions
Cortactin also participates in the organization of at least two major types of intercellular contacts: TJs and adherens junctions (AJ) (FIGURE 2F). TJs are composed of transmembrane contact proteins such as the occludins and their intracellular binding partners, predominantly the members of the zonula occludens (ZO) family (87) . TJs separate the apical and the basolateral membrane compartments, and the tightness of these structures determines transepithelial electrical resistance (TER) and paracellular transport. The cortactin SH3 domain has been shown to bind to the proline-rich region of ZO-1. Although little is known about the function of cortactin at the TJ, some functional studies support a positive role. Sphingosine-1 phosphate induced barrier enhancement (i.e., an increase in TER) in lung epithelial cells, which seemed to be mediated by Rac-dependent peripheral translocation of cortactin and MLCK. Downregulation of cortactin or elimination of its tyrosine phosphorylation prevented this effect (25) . The barrier-enhancing role of the cortactin-MLCK complex is an intriguing finding since increased myosin-based contractility usually reduces epithelial tightness. Future studies should address whether this effect is related to ZO-1. Recently, ZO-1 was also detected in the leading edge of fibroblasts migrating in a wound, where it was suggested to initiate integrin-dependent adhesion complexes (88) . AJs are composed of cadherins, which are homotypic transmembrane adhesion molecules linked to intracellular plaque proteins, ␤-catenin and then ␣-catenin, which in turn anchor the complex to the actin skeleton (90) . choline-induced currents (32) . Thus cortactin regulates ion channels and dynamically modifies synapses, which may play a role in synaptic plasticity and longterm potentiation. Indeed, evidence is accumulating that cortactin impacts on complex functions such as learning and sleep (20, 68) . Clearly, the neuronal career of cortactin has only started.
Cortactin at Endocytic Vesicles
The recognition that cortactin may play a role in endocytosis stemmed from two pioneering observations. The first was that cortactin associates with endocytic vesicles in an asymmetric manner, such that it accumulates on one pole of the vesicle, consistent with a role in actin polymerization-propelled intracellular trafficking of endosomes (45) . The second finding was that cortactin binds to the proline-rich domain of dynamin, a large GTPase that pinches off the forming endocytic vesicle (67) . The role of cortactin was then solidified by findings that 1) it accumulates at the clathrin-coated pits (CCPs) and 2) microinjection of anti-cortactin antibodies (12) , siRNA-induced knockdown (14, 108) , or the overexpression of the isolated SH3 domain inhibits endocytosis (12) . Endocytosis is a complex process involving pit formation, invagination, scission, and vesicle movement away from the membrane. Recent studies shed some light on cortactin's involvement in these particular steps. Merrifield et al. (69) studied the dynamics of individual CCPs using evanescent field microscopy and a witty technique, the pH-sensitive labeling of transferrin receptors, with which the closure and scission of CCPs can be resolved in real time. They found that cortactin starts accumulating early on at the forming pit, and its peak recruitment is coincident with scission. They propose that cortactin, by inducing local actin polymerization, promotes pit invagination, which facilitates efficient scission. Cortactin is not found in every forming pit, so it may mark a subset of CCPs. The role and mode of the cortactin-dynamin interaction is also emerging. It seems that dynamin can accumulate in an F-actin-independent manner and then recruits cortactin to the pit (14) . Interestingly, cortactin engaged in actin polymerization (i.e., associated with F-actin and Arp2/3) has an eightfold higher affinity for dynamin (108) . This means that dynamin will localize spots of active actin polymerization to the pit, which may be a central mechanism to coordinate invagination and subsequent fission (FIGURE 2E). Moreover, the role of the cortactin-dynamin complex is not limited to clathrin-mediated endocytosis, as inhibition of these molecules suppresses the clathrin-independent endocytosis of ␥c cytokine receptors (80) too. Cortactin seems to affect the fate of the endocytosed receptors as well. Remarkably, its overexpression inhibited the ubiquitylation and subsequent degradation of the EGF receptor, an effect that might contribute to the mutants, but not with tyrosine phosphorylationincompetent mutants, inhibited contact zone extension between neighboring cells (34) . These results suggest that cortactin participates in the biogenesis of epithelial AJs, presumably by regulating peripheral actin assembly, and thus membrane dynamics, necessary for the interaction of contact-forming cells (2) . In fibroblast, N-cadherin engagement initiated transient Rac-dependent cortactin recruitment to the nascent contacts along with Fer kinase-mediated cortactin phosphorylation at this locus. Using N-cadherin-covered beads and shear wash-off assays, we showed that both the presence of cortactin and its tyrosine phosphorylation are critical for providing adhesion strength for the newly formed contacts (27, 28) . Fermediated cortactin phosphorylation increased N-cadherin mobility, which may be required for N-cadherin clustering and contact zone extension. These findings render cortactin a key regulator of AJ formation and adhesion strength. In addition, cortactin may regulate the permeability and dynamics of mature AJs as well, since downregulation of cortactin in endothelial cells impaired the transmigration of polymorphonulear leukocyets through the monolayer (106) .
Cortactin at Sites of Cell-Pathogen Interactions
Cortactin has also emerged as a common target of pathogen-host cell interactions. Depending on the particular microbe, cortactin has been implicated in adhesion (e.g., pedestal formation by enteropathogenic an enterohemorrhagic Esherichia coli), invasion (Shigella, Neisseria, Chlamydia, Rickettsia, Staphylococcus, Crytosporodium), intracellular movement (actin polymerization-propelled motility, using actin comet tails by Listeria, Shigella, and vaccinia virus), and cell scattering (Helicobacter). All these processes harness the actin cytoskeleton of the host in various ways (86) . Intriguingly the effect on tyrosine phosphorylation is pathogen dependent, with robust increase (e.g., Shigella), no change (e.g., Chlamydia), or decrease (Helicobacter). Details of this rich and important topic go beyond the scope of the present paper, so the interested reader is referred to a recent excellent review (85) .
Cortactin in the Future
What can then be, if not the Holy Grail, at least the unifying principle underlying this wide diversity of potential functions, extending from cell migration/invasion through synaptic plasticity to intercellular contacts and more? Although only the future can provide a better insight, it seems likely that cortactin is one of those important molecular integrators that participate in the conversion of external (ligand-induced or mechanical) cues to appropriate membrane responses by organizing the cytoskeleton to execute the "desired" membrane remodeling. Progress in the following years is likely to solidify the link between the biochemistry and the physiology of cortactin. We hope to learn the molecular details whereby cortactin regulates cell migration, controls proteolysis during metastasis, and modifies intercellular contacts. We also hope to learn what exactly its tyrosine phosphorylation is doing. Moreover, cortactin will teach us about fundamental relationships between processes that today we view as separate entities. Thus it will help us to address the link and coordination between endo-or exocytosis and lamellipodial dynamics, or between cell migration and intercellular contact formation. There is little doubt that the gray eminence will continue to intrigue us.
